Interpreting treatment differences when patients drop out of a clinical trial

AIDS Patient Care and STDs

Volumn 12, Issue 4, 1998, Pages 275-285

  Lindsey, Jane C ^a   McGrath, Nuala M ^a  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; DRUG RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT;

EID: 0031841443     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.275     Document Type: Article

References (21)

1. Heyting A, Tolboom JT, Essers JG. Statistical handling of drop-outs in longitudinal clinical trials. Stat Med 1992;11:2043-2061.
2. Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis (with discussion). Appl Stat 1994;43:49-93.
3. Little RJ. Modeling the drop-out mechanism in repeatedmeasures studies. J Am Stat Assoc 1995;90:1112-1121.
4. Hogan JW, Laird NM. Intention-to-treat analyses for incomplete repeated measures data. Biometrics 1996;52:1002-1017.
5. Spector SA, Gelber RD, McGrath NM, et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. N Engl J Med 1994;331:1181-1187.
6. Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley, 1987, pp. 14-17.
7. Laird NM. Missing data in longitudinal studies. Stat Med 1988;7:305-315.
8. + lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J AIDS 1993;6:1103-1113.
9. Lavori PW. Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology 1992;6:39-48.
10. Lindsey JC, McKinney RE, Propert KJ. Issues in the conduct of clinical trials for HIV-infected children. In: AIDS clinical trials, Finkelstein DM, Schoenfeld DA, (eds.). New York: Wiley, 1995, pp. 267-286.
11. Shrout PE. Clinical trials in psychiatry: a comment. Neuropsychopharmacology 1992;6:49-50.
12. Raboud JM, Montaner JS, Thorne A, et al. Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. J AIDS 1996;12:46-55.
13. Rosner B. Fundamentals of biostatistics. Boston: Duxbury Press, 1988, pp, 458-463.
14. Crowder MJ, Hand DJ. Analysis of repeated measures. London: Chapman and Hall, 1990, pp. 152-156.
15. Wei LJ, Lachin JM. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984;79:653-661.
16. Wei LJ, Johnson WE. Combining dependent tests with incomplete repeated measurements. Biometrika 1985;72:359-364.
17. Dawson JD, Lagakos SW. Analyzing laboratory marker changes in AIDS clinical trials. J AIDS 1991;4:667-676.
18. Dawson JD, Lagakos SW. Size and power of two-sample tests of repeated measures data. Biometrics 1993; 49:1022-1032.
19. Schluchter MD. Methods for the analysis of informatively censored longitudinal data. Stat Med 1992;11: 1861-1870.
20. Draper N, Smith H. Applied regression analysis. New York: Wiley, 1981, pp. 141-183.
21. Dawson JD. Stratification of summary statistics tests according to missing data patterns. Stat Med 1994;13: 1853-1863.